Cancer Vaccines

Aetna considers the listed cancer vaccines experimental and investigational and not covered—specifically: helper multi‑peptide (6MHP) for metastatic melanoma; HLA‑A24‑binding peptide vaccines for gastric cancer; melanoma/Theraccine/Oncophage vaccine for any indication; p16(INK4a)‑based peptide vaccines for HPV‑associated cancers; and p62 DNA vaccine (Elenagen) for solid tumors—because safety and effectiveness have not been established.

"None explicitly covered. The policy identifies cancer vaccines and listed vaccine therapies as experimental and investigational and therefore not established as safe and effective for the indicatio..."

Sign up to see full coverage criteria, indications, and limitations.